Eur Respir J 2000; 15: 955-957
Copyright © ERS Journals Ltd 2000
Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis
S Cunningham,
McColm JR,
LP Ho,
AP Greening,
and
TG Marshall
Identifying noninvasive markers of pulmonary inflammation would be useful in assessing new therapies in children. Breath condensate is a simple and potentially acceptable sample medium even in small children. The technique has previously been used in adults, but not children with cystic fibrosis. The technique was assessed in 36 children with cystic fibrosis (mean age 10.4 yrs) and 17 control subjects, analysing samples for nitrite, interleukin(IL)-8 and salivary and nasal contamination. Correlations were made between levels of the inflammatory markers and forced expiratory volume in one second/forced vital capacity, chest radiograph score and use of inhaled steroids. On samples without significant contamination (<10 u x L(-1) amylase) nitrite was detected in 93% of samples at a median concentration of 3.0 microM compared with 50% of control samples at a median of 0.5 microM. Condensate amylase levels did not correlate with the nitrite value obtained (r=0.31). IL-8 was detected in 33% of CF samples. Breath condensate is an acceptable method of sample collection in children. Nitrite was raised in breath condensate from patients with cystic fibrosis when compared with control subjects.
This article has been cited by other articles:

|
 |

|
 |
 
J.-L. Corhay, M. Henket, D. Nguyen, B. Duysinx, J. Sele, and R. Louis
Leukotriene B4 Contributes to Exhaled Breath Condensate and Sputum Neutrophil Chemotaxis in COPD
Chest,
October 1, 2009;
136(4):
1047 - 1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malinovschi, C. Janson, L. Holm, L. Nordvall, and K. Alving
Basal and induced NO formation in the pharyngo-oral tract influences estimates of alveolar NO levels
J Appl Physiol,
February 1, 2009;
106(2):
513 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Montuschi
Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications
Therapeutic Advances in Respiratory Disease,
October 1, 2007;
1(1):
5 - 23.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Sagel, J. F. Chmiel, and M. W. Konstan
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
Proceedings of the ATS,
August 1, 2007;
4(4):
406 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Corhay, L. Hemelaers, M. Henket, J. Sele, and R. Louis
Granulocyte Chemotactic Activity in Exhaled Breath Condensate of Healthy Subjects and Patients With COPD
Chest,
June 1, 2007;
131(6):
1672 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre
Exhaled breath condensate: methodological recommendations and unresolved questions
Eur. Respir. J.,
September 1, 2005;
26(3):
523 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Marteus, D C Tornberg, E Weitzberg, U Schedin, and K Alving
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation
Thorax,
March 1, 2005;
60(3):
219 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov
Breath Condensate pH in Children With Cystic Fibrosis and Asthma: A New Noninvasive Marker of Airway Inflammation?
Chest,
June 1, 2004;
125(6):
2005 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Baraldi, L Ghiro, V Piovan, S Carraro, F Zacchello, and S Zanconato
Safety and success of exhaled breath condensate collection in asthma
Arch. Dis. Child.,
April 1, 2003;
88(4):
358 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Formanek, D. Inci, R.P. Lauener, J.H. Wildhaber, U. Frey, and G.L. Hall
Elevated nitrite in breath condensates of children with respiratory disease
Eur. Respir. J.,
March 1, 2002;
19(3):
487 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. De Rose
Mechanisms and markers of airway inflammation in cystic fibrosis
Eur. Respir. J.,
February 1, 2002;
19(2):
333 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. MUTLU, K. W. GAREY, R. A. ROBBINS, L. H. DANZIGER, and I. RUBINSTEIN
Collection and Analysis of Exhaled Breath Condensate in Humans
Am. J. Respir. Crit. Care Med.,
September 1, 2001;
164(5):
731 - 737.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Balint, S.A. Kharitonov, T. Hanazawa, L.E. Donnelly, P.L. Shah, M.E. Hodson, and P.J. Barnes
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
Eur. Respir. J.,
June 1, 2001;
17(6):
1201 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the European Respiratory Society.
|